Healthcare in 2022: what you need to know
With the Covid-19 pandemic sending shockwaves in the hospital sector, healthcare providers will continue looking for ways to slowly rebuild …
Post
-
-
Phantom Neuro secures approval for muscle-machine interface trial
Phantom Neuro has secured approval to initiate its first-in-human trial of the Phantom X system, a minimally invasive muscle-machine interface, …
-
Precision receives CTA approval to expand ELIMINATE-B study
Precision BioSciences has received clinical trial application (CTA) approval to expand its global ELIMINATE-B study of PBGENE-HBV, an in vivo …
-
Boehringer Ingelheim and Zai Lab team up for dual DLL3 therapy study
Boehringer Ingelheim and Zai Lab have entered a clinical collaboration to investigate a dual delta-like ligand 3 (DLL3)-targeting approach for …
-
GlycoNex secures Japan’s PMDA approval for GNX1021 Phase I trial
GlycoNex has received Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) approval to commence a first-in-human Phase I clinical trial of …
-
AIP to acquire Avanos Medical for $1.27bn
US-based Avanos Medical has entered a definitive agreement to be acquired by affiliates of American Industrial Partners (AIP) in an …
-
Healthcare in 2022: what you need to know
With the Covid-19 pandemic sending shockwaves in the hospital sector, healthcare providers will continue looking for ways to slowly rebuild …
-
Lilly to acquire CrossBridge Bio for up to $300m
Eli Lilly and Company has agreed to acquire all outstanding shares of CrossBridge Bio for up to $300m in cash, …
-
J&J reports 12-month data for Varipulse PFA platform
Johnson & Johnson (J&J) has reported interim 12-month results from the VARIPURE study, assessing the effectiveness and safety of its …
-
Vir Biotechnology doses first patient in Phase I VIR-5500 trial
Vir Biotechnology has dosed the first patient in one of three expansion cohorts in its ongoing Phase I clinical trial …
-
MSD, Daiichi Sankyo’s ifinatamab deruxtecan receives FDA priority
Merck & Co (MSD) and Daiichi Sankyo have received priority review from the US Food and Drug Administration (FDA) for …
-
Zebra Technologies and Aiva Health team up on nurse solutions
Zebra Technologies and Aiva Health have collaborated to support hands-free nurse workflows with Aiva's AI-powered solution. This partnership integrates Aiva’s AI-based …
-
FDA issues complete response letter to Replimune’s RP1 for melanoma
The US Food and Drug Administration (FDA) has issued a complete response letter (CRL) to Replimune Group’s biologics licence application …
-
BioNTech and DualityBio report positive data for trastuzumab pamirtecan
BioNTech and DualityBio reported encouraging data from a Phase II cohort of their global clinical study evaluating the efficacy of …
-
GE HealthCare and Medtronic integrate bkActiv iUS and Stealth AXiS system
GE HealthCare has integrated its bkActiv intraoperative ultrasound (iUS) system with Medtronic's Stealth AXiS surgical navigation system to provide imaging …
-
AllRock Bio begins patient dosing in Phase IIa ROCSTAR trial
AllRock Bio has dosed the first patients in the Phase IIa ROCSTAR clinical trial investigating ROC-101, an oral pan-rho-associated protein …
-
Gan & Lee and JW Pharmaceutical agree on bofanglutide commercialisation
Gan & Lee Pharmaceuticals has entered an exclusive licence agreement with JW Pharmaceutical for the clinical development, regulatory approval, and …
